TNON
Tenon Medical, Inc.NASDAQHealthcare$0.72+3.95%ClosedMarket Cap: $5.3M
As of 2026-04-06
Valuation
View DetailsP/E (TTM)
—
PEG
—
P/B
1.60
P/S
1.39
EV/EBITDA
-0.15
DCF Value
$-63.07
FCF Yield
-200.5%
Div Yield
0.0%
Margins & Returns
Gross Margin
59.1%
Operating Margin
-323.6%
Net Margin
-316.0%
ROE
-193.2%
ROA
-116.4%
ROIC
-166.8%
Financials
View All| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q4 2025 | $1.5M | $-2.8M | $-0.26 |
| FY 2025 | $3.9M | $-12.6M | $-1.70 |
| Q3 2025 | $1.2M | $-3.3M | $-0.40 |
| Q2 2025 | $564.0K | $-2.8M | $-0.36 |
Trading Activity
Insider Trades
View AllWilliamson Kevinofficer: Chief Financial Officer
SellThu Mar 05
FOSTER STEVEN Mdirector, officer: CEO and President
SellMon Jan 05
Hochschuler Stephendirector
SellMon Jan 05
Hochschuler Stephendirector
SellMon Jan 05
WEIGLE ROBERT Kdirector
SellMon Jan 05
Company Info
Sector
Healthcare
Industry
—
Country
US
Exchange
NASDAQ
Beta
1.25
Tenon Medical, Inc., a medical device company, develops surgical implant systems to optimize sacroiliac joint fixation/fusion surgery and corresponding outcomes. It sells The CATAMARAN SIJ Fusion System that includes instruments and implants designed to prepare and fixate the SI-Joint for fusion in the United States and Puerto Rico. The company was founded in 2012 and is based in Los Gatos, California.